Oxcarbazepine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Oxcarbazepine. Educational only — not medical advice.
Labeled uses
Oxcarbazepine tablets are indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults and as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above and as adjunctive therapy in pediatric patients aged 2 years and above with partial-onset seizures.
Source: FDA labeling via NIH DailyMed (set 21b0cc84…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.